statement (15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30): Assessing expression of five principal (pro)epicardial markers reveals their complete overlap during early embryonic development, challenging previous dogma regarding the existence of sub-compartments and the pre-committed fate model. Abstract: During embryonic development, the epicardium provides a source of multipotent progenitors for cardiac lineages, including pericytes, fibroblasts and coronary smooth muscle cells. The epicardium originates from a region of splanchnopleural mesoderm known as the proepicardial organ (PEO). The potential of the epicardium to contribute to coronary endothelium has been disputed, due to conflicting lineage tracing results with different PEO Cre lines. Controversy also surrounds when epicardial cell fate becomes restricted. Using single-cell RNA-sequencing, microscopy and flow cytometry-based single molecule RNA in situ hybridisation techniques, we systematically investigated the expression of five widely used epicardial markers, Wt1, Tcf21, Tbx18, Sema3d and Scx, over the course of development.
Results & Discussion
1. PEO cells that transition to the epicardium co-express Wt1, Sema3d, Tbx18, Scx and
Tcf21
We used single molecule RNA in situ hybridisation (RNAscope) on E9.5 sagittal mouse embryonic sections, to detect expression of Wt1, Sema3d, Tcf21, Scx and Tbx18, markers previously employed for PEO lineage tracing (Wang et al., 2012) (Fig. 1A-B ). Three probes were multiplexed to allow simultaneous detection of the different markers. We observed complete overlap of marker expression in the PEO and in cells actively migrating towards the heart (Fig. 1C, Fig. S1A-B ). Morphologically, proepicardial cells are defined as the protrusions/villi that extend from the ST region (Maya-Ramos et al., 2013) . Based on our data, the bona fide PEO co-expresses all tested markers. Below the proepicardium, the markers labelled distinct domains of expression that only partially overlapped ( Fig. S1A-B ). Wt1 and Tcf21 are known to be expressed in the hepatic primordium, also located in the ST (Lu et al., 2000; Perez-Pomares et al., 2004) , whereas Tbx18 expression is found in cardiomyocyte precursors present in the region (Christoffels et al., 2009 ).
To determine the marker profile of PEO cells that reach the heart and give rise to the definitive epicardium, we multiplexed RNAscope probes on E10.5 sagittal sections. Cells in contact with the heart surface co-expressed all markers ( Fig. 1 C-D, Fig. S1A-B ), although Scx expression decreased significantly compared to E9.5 ( Fig. 1D ). To independently confirm the RNAscope findings, we analysed published single-cell RNA-sequencing data from E10.5 mouse hearts (Dong et al., 2018) . Clustering was performed using the significant principal components identified by Seurat, which classified the cells into three populations: epicardium (Epi), endocardium/atrioventricular cushion (Endo/AVCu) and cardiomyocytes (CM), shown here using the t-distributed stochastic neighbour embedding algorithm (tSNE) ( Fig. 1E; Fig. S1C ) (Butler et al., 2018; Platzer, 2013; Ratnadiwakara et al., 2018) . Wt1, Sema3d, Tcf21 and Tbx18 were expressed in 97-100% of the epicardial cluster at E10.5, alongside mesothelial genes such as Upk3b and Upk1b. Scx was only expressed in 26% (Fig. 1F ), but this may reflect the low capture rate of STRT-Seq technology (Ziegenhain et al., 2017) .
Our findings show that proepicardial cells that transition onto the heart to form the epicardium co-express all the tested markers, contrasting with previous reports (Katz et al., 2012) . The disparate findings most likely reflect a failure to distinguish the ST mesenchyme from the proepicardium. The ST mesenchyme is widely heterogeneous, containing precursors for a multitude of lineages, ranging from cardiomyocytes (Christoffels Vincent et al., 2006) to haematopoietic cells (Cañete et al., 2017) . It is challenging to separate the proepicardium from the rest of the ST as there are no defined molecular boundaries and previously used markers, such as Wt1 or Tbx18, are also expressed in ST mesenchyme (Cai et al., 2008; Carmona et al., 2016) . Our findings explain the differential potential of proepicardial/ST explants vs epicardial explants, with the former able to give rise to cardiomyocytes and endothelial cells, which are not present in epicardial outgrowths (Greulich and Kispert, 2013; Red-Horse et al., 2010; Ruiz-Villalba et al., 2013) . We hypothesize that endothelial precursors, expressing markers such as Scx, might exist in the ST region and contribute to the heart, but transition via a non-epicardial route. Indeed, the proepicardial/ST markers used to infer coronary endothelial contribution, namely Scx, Sema3d and Gata4, also lineage-label cells in the SV/Endocardium (Cano et al., 2016; Katz et al., 2012) , suggesting these precursors may contribute via the main CEC sources.
Wt1 CreERT2 induction at E9.5 efficiently labels the epicardium
A key question is how the expression of epicardial markers changes throughout the course of development, both within the epicardial layer and in EPDCs as they differentiate. We used the inducible Wt1CreERT2 (Zhou et al., 2008) , crossed with Rosa-tdTomato reporter (Madisen et al., 2010) , to label the early embryonic epicardium and enable tracing of the epicardial lineage.
Maximal Cre recombination efficiency is reported to occur 24h-48h following tamoxifen delivery, therefore we administered tamoxifen at E9.5 in order to label the epicardium at E10.5 -E11.5, before EMT and before Wt1 is expressed in CECs, from E13.5 (Hayashi and McMahon, 2002; Zhou and Pu, 2012) . RNAscope was performed at E11.5, multiplexing probes against epicardial markers and against tdTomato to determine extent of epicardial labelling ( Fig. 2A-F ). TdTomato efficiently labelled the epicardial layer, and careful inspection of high power images indicated an overlap with all epicardial markers throughout the entire epicardial layer ( Fig. 2A-F ). The only exception was a distinct population of tdTomato+ cells, located in the AV groove, which were positive for Tcf21 ( Fig. 2A, D) . These cells derived from the Wt1 lineage, as indicated by tdTomato expression, but down-regulated Wt1, Tbx18, Sema3d and Scx expression; Fig. 2A-F ), suggesting the earliest transition to EPDCs from this region at E11.5. Some of the markers were detected in non-epicardial domains, Tbx18 in cardiomyocytes ( Fig. 2E ) and Scx and Tcf21 in AVCu (Fig. 2D , F), confirming previous reports (Acharya et al., 2011; Barnette et al., 2014; Christoffels et al., 2009 ).
To quantitatively assess marker overlap at the single (whole) cell level, a flow cytometry-based RNA ISH method was utilised (PrimeFlow RNA Assay) (Lai et al., 2018) on enzymatically dissociated E11.5 hearts ( Fig. 2G; Fig. S2D ; with 90.6±0.2% WT1+ cells tdTomato labelled).
After exclusion of cardiomyocytes and endothelial/endocardial cells, >95% of tdTomato+ cells co-expressed Wt1, Tcf21, Sema3d and Tbx18. Scx expression was very low and detected only in 88.7%. We concluded that inducing Wt1CreERT2 at E9.5 efficiently labels the epicardium and its derivatives. We excluded the possibility that slight variations in Wt1 expression might influence recombination efficiency by analysing non-lineage traced epicardial cells, which similarly co-expressed markers (e.g 97% and 92% Wt1+ cells expressed Sema3d and Tcf21, respectively; Fig. S1D ). Expression levels measured for each marker fell within a limited dynamic range, as observed for the housekeeping gene Actb (Fig.   S1D ), and may reflect fluctuations associated with cell cycle or bursts in RNA production (Corrigan et al., 2016; Tirosh et al., 2016; Weinreb et al., 2018) . Importantly, multiplexed probe sets were carefully selected to ensure highest assay channel sensitivity as fluorophore intensities between Alexa Fluor 488, 647 and 750 differ ( Fig. S1D ).
3. Epicardial markers are sequentially downregulated in the epicardium as development progresses Next, we used the above labelling strategy to trace the epicardial lineage throughout the course of embryonic development, facilitated by tdTomato reporter expression ( Fig. 3A ). After tamoxifen delivery at E9.5, hearts were analysed at key developmental stages: E11.5, when epicardium formation is complete; E13.5, when epicardial cells invade the myocardium; E15.5, when epicardial EMT ceases and E17.5, when EPDCs have differentiated. The expression of each epicardial marker against tdTomato reporting was assessed at every stage by RNAscope and Primeflow ( Wt1 was expressed in the endothelium after E13.5 ( Fig. S2B; Fig. S3E -G) and Tcf21 in the interstitial cells ( Fig. S2C ), confirming other published data (Acharya et al., 2011; Zhou and Pu, 2012) . Due to the non-specificity of these markers, we focused on tdTomato+ cells, representing the epicardial lineage, for our subsequent analyses.
To assess co-expression of markers in the epicardial lineage across these stages, two different probe combinations were used for PrimeFlow on tdTomato+ hearts: Sema3d/Wt1/Tcf21 and Sema3d/Scx/Tbx18 with Sema3d serving to ensure parity across probe sets( Fig. 3B , gating only on tdTomato+ cells, Fig. S3A ), and the proportion of tdTomato+ cells expressing each marker was quantified at every stage ( Fig. 3C ). At E11.5, tdTomato+ cells almost exclusively (>95%) represented the epicardium, which continued to co-express all marker genes ( Fig. 3A-C, Fig. S3A ). From E13.5, we detected the emergence of EPDCs, as shown by tdTomato+ cells present within the myocardium, and by the appearance of a distinct additional population of cells in the flow cytometry scatter plots, which had decreased expression of Sema3d, Wt1, Tbx18 and Scx (Fig. 3B, Fig. S3A ). The number of EPDCs increased as development progressed, exceeding the number of cells within the epicardial layer ( Fig. 3A-C) , however, the combined number of epicardial and epicardium-derived cells, as a proportion of the total heart cells, remained constant throughout development, at around 12% (Fig. 3D ). The expression of all epicardial markers was downregulated, and eventually lost, in EPDCs, with the exception of Tcf21, which increased ( Fig. 3B ). All EPDCs were positive for Tcf21 at E13.5, implying that Tcf21 expression is not sufficient to determine cell fate. From E15.5, Tcf21 was downregulated in a subpopulation of EPDCs, coinciding with the appearance of epicardium-derived mural cells (Volz et al., 2015) , (Fig. 3B ).
Expression of Sema3d, Wt1, Tcf21 and Tbx18 peaked within the epicardium at E11.5, as assessed by both RNAscope and PrimeFlow ( Fig. 3E -F). Tcf21 expression was dramatically reduced beyond E13.5 in the epicardium, being almost undetectable in some of the cells, followed by a reduction in Tbx18 expression ( Fig. 3E, Fig. S4A-B ), to coincide with completion of epicardial EMT by E15.5 , and onset of epicardial quiescence. Wt1 and Sema3d continued to be co-expressed in the entire epicardium throughout embryonic development, albeit at lower levels ( Fig. 3F; Fig. S4A-B ). Although markers were sequentially downregulated, marker expression remained discernibly homogeneous between individual epicardial cells; thus, our study found no evidence of discrete sub-populations, at least at the level of the markers tested.
4. The epicardium produces multipotent progenitors that contribute to cardiac fibroblasts and mural cells, but not to endothelium To further investigate the epicardial lineage in greater detail, we performed single-cell RNAsequencing of tdTomato+ FACS sorted cells at E15.5, a stage when derivative fates manifest (Picelli et al., 2014) . Five transcriptionally-distinct populations were identified using the significant principal components and visualized with tSNE, as facilitated by Seurat (Butler et al., 2018; Stuart et al., 2018) (Fig. 4A ). The first cluster represented the epicardium (Epi), based on expression of mesothelial genes, such as Upk3b (Fig. S4C ). Two mesenchymal clusters were identified, the first (Mes1) presented a transcriptional profile consistent with the subepicardial mesenchyme reported by Xiao et al., whereas the second cluster (Mes2) was more mature, expressing genes such as Postn (Xiao et al., 2018) . A proliferating cluster was also identified (Pro), bearing a transcriptional signature similar to the Mes2 cluster. The fifth cluster represented the epicardium-derived mural cells and expressed multiple pericyteassociated genes, such as Cspg4 or Rgs5. We used a dot plot to analyse expression of epicardial markers within the different clusters ( Fig. 4B-C) . Sema3d and Wt1 were expressed in the entire epicardial cluster (100%; Fig.4B ), whereas their expression was lower in the mesenchymal populations and almost undetectable in the mural cluster. Levels of Tcf21 in the epicardium were very low, however expression was high in both mesenchymal clusters. Tbx18 was mainly localised to the epicardium and the mural cell cluster, whereas Scx was detected in 69% of the epicardial cluster ( Fig. 4B-C) , likely due to its very low expression.
We used Monocle2 to classify cells based on pseudotime, in order to reconstruct the differentiation trajectory of the epicardial lineage (Qiu et al., 2017a; Qiu et al., 2017b; Trapnell et al., 2014) . The developmental trajectory obtained was very similar to that reported by Xiao et al., with one branching point leading towards differentiated cells (branch A) and one consisting of more mesenchymal cells (branch B) ( Fig. 4D) (Xiao et al., 2018) . In our case, branch A was associated with expression of mural genes, such as Pdgfrβ and Rgs5, whereas branch B had higher expression of fibroblast-like genes, such as Pdgfrα and Dpt (Fig. S4D ).
Expression of Sema3d, Wt1, Tcf21, Tbx18 and Scx was visualised across the trajectory. None of the genes showed branch-dependent expression, suggesting their expression is not sufficient to restrict cell fate (Fig. 4E ). The branch point occurred after mesenchymal cells first emerged, suggesting that cell fate may be specified in EPDCs post-EMT. This model contradicts a previous report, which suggested that fate restriction of EPDCs occurred prior to EMT (Acharya et al., 2012) . Tcf21 was concluded to be required only for EMT of epicardial cells destined to become fibroblasts, because PDGFRα+, but not PDGFRβ+, cells were absent from Tcf21 global knock out embryos. However, another study showed that Tcf21 is required for normal formation of the entire epicardium, raising questions about the ability of Tcf21-depleted epicardial cells to undergo EMT altogether (Tandon et al., 2013) . Recently, the endocardium was identified as an alternative source of mural cells in the heart, therefore it is possible the PDGFRβ+ cells present in Tcf21 mutants derived from this compartment (Chen et al., 2016) . This controversy could be resolved in future by conditional deletion of Tcf21 and lineage tracing with Wt1 CreERT2 to assess the origin of the mural cells in these hearts.
In addition to the single-cell RNA-sequencing, we also performed flow cytometric analysis at E17.5 to quantify epicardial contribution to the coronary endothelium, labelled with CD31 (excluding endocardial cells by Npr3 expression ). Of the CD31+Npr3population, tdTomato+ cells averaged just 3.4% (Fig. 4F ). Wt1-lineage contribution to CECs seems to be negligible, which is in agreement with previous reports (Cai et al., 2008; Zhou and Pu, 2012) .
In conclusion, our data show an overlap in expression of the epicardial markers Wt1, Tcf21, Sema3d, Tbx18 and Scx, in the epicardium early in development, with minimal variation in level of expression between cells. We postulate that previous, contrasting (non-inducible) lineage tracing results may reflect expression of the Cre-driver in non-epicardial lineages, rather than the existence of subpopulations within the epicardial layer. Genes outside the tested 'canonical epicardial signature' may be heterogeneously expressed (Bollini et al., 2014; Cao et al., 2016) , however, based on single-cell RNA-sequencing inferred developmental trajectories, we suggest that the fate of epicardium-derived cells is specified after EMT, potentially due to extrinsic signalling (Schematic, Fig. 4G ).
Materials & Methods:
Mouse strains: Wt1 CreERT2 (Zhou et al., 2008) , Rosa26 tdTomato (Madisen et al., 2010) alleles have been previously described. Males homozygous for the Rosa26 tdTomato allele and heterozygous for Wt1 CreERT2 were crossed with C57BL/6 females to generate embryos. The mice used were on a C57BL/6 genetic background. Pregnant females were oral gavaged with 80mg/kg tamoxifen (Sigma, #T5648) 9 days after the mating plug was detected. Tamoxifen was dissolved in peanut oil with 10% ethanol at a final concentration of 10mg/ml. The animals were kept in a controlled environment and all procedures used were approved by the University of Oxford Animal Welfare and Ethical Review Boards in accordance with Animals (Scientific Procedures) Act 1986 (Home Office, United Kingdom).
RNAscope & Immunofluorescence:
RNAscope is a commercially available in-situ hybridization assay provided by Advanced Cell Diagnostics (ACD). RNAscope was performed on 8-12 μm thick embryonic cryosections that had been fixed for 2h in 4%PFA and embedded in OCT (Tissue-Tek). The following catalogue probes were used: Wt1 #432711), Sema3d (#488111), Tcf21 (#508661), Tbx18 (#515221), Scx (#439981), tdTomato (#317041). The 3-plex negative probe against dapB was used as a negative control (#320878). The RNAscope Multiplex Fluorescent Reagent Kit v2 assay was performed according to manufacturer's instructions, except for the target retrieval step which was reduced to 10min and the Protease Plus digestion which was performed at room temperature (RT). The TSA plus fluorophores (PerkinElmer, NEL753001KT, NEL745E001KT) were used at 1:500 final concentration for Fluorescein, 1:1000 for Cy3 and 1:1500 for Cy5.
For immunostaining the cryosections were rehydrated for 15 min in PBS, then permeabilised in PBS + 0.5%triton for 15 min at RT, followed by blocking in PBS + 10% goat serum +1% bovine serum albumin (BSA) for 1h at RT and incubation with primary antibody diluted in blocking buffer overnight at 4°C. The sections were rinsed three times, then washed three times in PBS + 0.1% Triton X-100, then the secondary antibodies diluted in blocking buffer were added for 1 hour, RT. The sections were rinsed three times in PBS containing 0.1% Triton X-100, then washed twice for 5 min/each wash, followed by 5 min incubation with DAPI nuclear stain. The slides were mounted in Vectashield (Vector Laboratories, H-1000).
Antibodies used: WT1 1:100 dilution (Abcam, ab89901), CD31/Pecam1 1:100 dilution (Abcam, ab119341).
Sections were imaged using a Leica DM6000 fluorescence microscope and Olympus
Fluoview-1000 confocal microscope and processed using Fiji.
PrimeFlow RNA Assay & Flow Cytometry:
Hearts were enzymatically dissociated using the Neonatal Heart Dissociation Kit (#130-098-373) and the gentleMACS Octo Dissociator with heaters (#130-096-427) from Milteny Biotec according to manufacturer's instructions. The dissociated hearts were further processed using the PrimeFlow RNA Assay Kit from ThermoFisher Scientific (#88-18005). Briefly, cells were surface stained with the Zombie Aqua Fixable Viability Kit (Biolegend, #423101) for 0.5hr at RT,1:1000 dilution, followed by BV421 rat anti-CD31 antibody (Biolegend, #102423) for 0.5hr on ice, 1:50 dilution. Samples were further fixed and permeabilised using reagents provided in the kit. Intracellular staining was performed using BV421 mouse anti-cardiac troponin T antibody (BD Bioscieces, #565618) for 0.5hr on ice, 1: For analysing the contribution of the epicardial lineage to endothelium hearts were dissociated and surface stained with viability dye as described above, then pre-treated for 5 min on ice with TruStain FcX (anti-mouse CD16/32) antibody (Biolegend, #101319), 1:50 to block Fcγ receptors. Cells were subsequently stained with BV605 rat anti-CD31 antibody, (Biolegend, #102427) on ice for 0.5hr, 1:50 dilution. Cells were fixed and permeabilised using the PrimeFlow kit reagents, then intracellularly stained with cTNT (as described above). Cells were stored in IC fixation buffer (ThermoFisher, #00-8222-49) until acquisition.
All samples were analysed using BD LSRFORTESSA X-20 cytometer and processed using FlowJo software. Percent positive was calculated using Super-Enhanced Dmax Subtraction algorithm (%SED; FlowJo) when comparing histograms (Supplementary information Table S1-S3). Geometric mean fluorescence intensity (gMFI) was calculated by subtracting fluorescence minus one (FMO) gMFI from sample gMFI.
Single-cell RNA-sequencing & Analysis:
E10.5 single-cell heart transcriptome data was downloaded as TPM from Gene Expression Omnibus (GSM3027035) (Dong et al., 2018) . The TPM values were log10 transformed and analysed using Seurat in R (http://www.R-project.org/ (Stuart et al., 2018) . In brief, the significant principal components were used to classify the cells into clusters and the tSNE method was used to visualise the clusters (Platzer, 2013) .
For the E15.5 single-cell RNA-Sequencing data, the ventricles from 6 embryonic hearts were dissociated (as described above) and BD FACSAria III was used to sort cells positive for tdTomato fluorescence into 96-well plates. The cells were processed according to the Smart-Seq2 protocol (Picelli et al., 2014) . Tagmentation and library preparation was done using the Nextera XT DNA Library Prep kit and sequenced using the NextSeq 500/550 High Output Kit v2 (75 cycles) 400 million reads (Illumina, #FC-404-2005) on Illumina NextSeq 500 platform.
BCL files from the sequencer were converted to FastQ with bcl2fastq (Illumina, v.2.19.1.403) using default settings. Samples with fewer reads in total than the empty wells were discarded.
Reads were trimmed using default settings and "--nextera" for adapter clipping (TrimGalore v.0.4.4). Random samples were checked with FastQC (v.0.11.3) to control for the quality of the sequence. Reads were aligned to the mouse genome (GRCm38/Mm10) with STAR (v.2.3.3a) in gene counting mode with Gencode (v.M16) annotations minus the megatranscript Gm20388 (Dobin et al., 2013) . Splice junctions from all samples were combined after the 1st pass alignment. Non-canonical junctions and junctions covered with < 10 reads were removed prior to running the 2nd pass alignment. The samples were further processed with Seurat.
Genes with > 200 reads in at least 3 cells were retained for downstream processing. Cells were filtered to retain those with < 5% mitochondrial genes and at least 500 expressed genes.
276 cells passed this threshold. Reads were normalized to sequencing depth and scaled. Cell cycle scores (G2M and S) was predicted using G2M and S phase genes (Kowalczyk et al., 2015) . The difference between the G2M and S phase score was regressed out using the cell cycle regression Seurat vignette. Clustering was performed as described above. The normalised data from Seurat was imported into Monocle2 for analysis of pseudotime (Qiu et al., 2017a) (Qiu et al., 2017b) . 
Figure legends

